Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis

被引:66
作者
Carlson, Dustin A. [1 ]
Crowell, Michael D. [3 ]
Kimmel, Jessica N. [1 ]
Patel, Amit [5 ]
Gyawali, C. Prakash [5 ]
Hinchcliff, Monique [2 ]
Griffing, W. Leroy [4 ]
Pandolfino, John E. [1 ]
Vela, Marcelo F. [3 ]
机构
[1] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA
[3] Mayo Clin, Div Gastroenterol & Hepatol, 13400 East Shea Blvd, Scottsdale, AZ 85253 USA
[4] Mayo Clin, Div Rheumatol, Scottsdale, AZ USA
[5] Washington Univ, Sch Med, Div Gastroenterol & Hepatol, St Louis, MO USA
关键词
Systemic Sclerosis; High-Resolution Manometry; Esophageal Motility; SCLERODERMA; MANOMETRY; CLASSIFICATION; METAANALYSIS; DYSMOTILITY; DISORDERS; RISK;
D O I
10.1016/j.cgh.2016.03.039
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We assessed peristaltic reserve using multiple rapid swallows (MRS) during esophageal high-resolution manometry (HRM) of 111 patients with systemic sclerosis (89 women; ages, 42-64 y). We performed a retrospective analysis of HRM studies that included MRS in patients with systemic sclerosis, performed at 2 tertiary referral centers, and compared data with those from 18 healthy volunteers (controls). HRM findings were analyzed according to the Chicago Classification to provide an esophageal motility diagnosis. Response to MRS was evaluated for the presence of contraction and for augmentation, defined as the distal contractile integral after MRS greater than the median distal contractile integral of 10 supine swallows. Esophageal motility diagnoses included 41% with absent contractility, 31% with normal motility, 23% with ineffective esophageal motility, and 5% that met the criteria for other esophageal motility disorders. Contraction (37%) and peristaltic augmentation (18%) after MRS were observed less frequently in patients with systemic sclerosis than in controls (83% and 100%, respectively). Impaired peristaltic reserve, as assessed with MRS during HRM, is therefore the most common esophageal motility finding among patients with systemic sclerosis.
引用
收藏
页码:1502 / 1506
页数:5
相关论文
共 21 条
[1]   GASTROINTESTINAL MANIFESTATIONS OF SYSTEMIC-SCLEROSIS [J].
ABUSHAKRA, M ;
GUILLEMIN, F ;
LEE, P .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1994, 24 (01) :29-39
[2]   Oesophageal manometry in early and definite systemic sclerosis [J].
Airò, P ;
Della Casa, D ;
Danieli, E ;
Missale, G ;
Cattaneo, R ;
Cestari, R .
CLINICAL RHEUMATOLOGY, 2005, 24 (04) :370-376
[3]   Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro-esophageal reflux disease [J].
Daum, C. ;
Sweis, R. ;
Kaufman, E. ;
Fuellemann, A. ;
Anggiansah, A. ;
Fried, M. ;
Fox, M. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 (06) :517-E200
[4]   Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis [J].
Eom, Chun-Sick ;
Jeon, Christie Y. ;
Lim, Ju-Won ;
Cho, Eun-Geol ;
Park, Sang Min ;
Lee, Kang-Sook .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (03) :310-319
[5]   Multiple rapid swallowing: a complementary test during standard oesophageal manometry [J].
Fornari, F. ;
Bravi, I. ;
Penagini, R. ;
Tack, J. ;
Sifrim, D. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (07) :718-E41
[6]   Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth [J].
Jacobs, C. ;
Adame, E. Coss ;
Attaluri, A. ;
Valestin, J. ;
Rao, S. S. C. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (11) :1103-1111
[7]   Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis [J].
Janarthanan, Sailajah ;
Ditah, Ivo ;
Adler, Douglas G. ;
Ehrinpreis, Murray N. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07) :1001-1010
[8]   The Chicago Classification of esophageal motility disorders, v3.0 [J].
Kahrilas, P. J. ;
Bredenoord, A. J. ;
Fox, M. ;
Gyawali, C. P. ;
Roman, S. ;
Smout, A. J. P. M. ;
Pandolfino, J. E. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (02) :160-174
[9]   EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) [J].
Kowal-Bielecka, O. ;
Landewe, R. ;
Avouac, J. ;
Chwiesko, S. ;
Miniati, I. ;
Czirjak, L. ;
Clements, P. ;
Denton, C. ;
Farge, D. ;
Fligelstone, K. ;
Foeldvari, I. ;
Furst, D. E. ;
Mueller-Ladner, U. ;
Seibold, J. ;
Silver, R. M. ;
Takehara, K. ;
Toth, B. Garay ;
Tyndall, A. ;
Valentini, G. ;
van den Hoogen, F. ;
Wigley, F. ;
Zulian, F. ;
Matucci-Cerinic, Marco .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) :620-628
[10]  
Lahcene M, 2011, ISRN Rheumatol, V2011, P325826, DOI 10.5402/2011/325826